# Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions

> **NCT01506713** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 53 (actual)

## Conditions studied

- Fasting

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01506713
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2012-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01506713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01506713, "Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01506713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*